Header Logo

Blockade of MK2 is protective in inflammation-associated colorectal cancer development.

Ray AL, Castillo EF, Morris KT, Nofchissey RA, Weston LL, Samedi VG, Hanson JA, Gaestel M, Pinchuk IV, Beswick EJ. Blockade of MK2 is protective in inflammation-associated colorectal cancer development. Int J Cancer. 2016 Feb 01; 138(3):770-5.

View in: PubMed